Clymb Clinical Introduces TFL Viewer: A Cutting-Edge Platform for Collaborative Clinical Trial Reporting

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

BURLINGTON, Mass., May 22, 2025 /PRNewswire/ — Clymb Clinical is proud to announce the launch of TFL Viewer, a state-of-the-art SaaS application designed to streamline the review, feedback, and approval process for Tables, Figures, and Listings (TFLs) in clinical trials. Built for Biotechnology, Pharmaceutical, Medical Device, and CRO companies, TFL Viewer enhances collaboration, efficiency, and accuracy in clinical reporting, ensuring seamless regulatory submission workflows.

“The launch of our TFL Viewer expands our TFL automation suite, adding another powerful solution to streamline development and review” said Co-Founder, Bhavin Busa. “Our TFL Viewer cuts through the clutter – no more messy reviews, scattered files, or complicated submissions. Just smooth collaboration, clear feedback, and easy access to your clinical trial results in one place.”

Co-Founder Colin Izzo added, “We have been amazed at the feedback we have received from our Clients and Community Users of TFL Designer which allows users to automate the design and generation of TFL Shells. Now, with our launch of TFL Viewer, we can further TFL Automation to include Clinical Development, Medical Monitors, Data Management, Regulatory and Medical Writing teams as well as Biostatistics – all within a centralized platform.”  

Clymb’s Head of IT & Software Engineering, Navin Dedhia, emphasized the importance of innovation in clinical trial analysis and reporting: “We firmly believe that by consolidating TFLs into a unified platform which contains intuitive automation and AI-driven content generation, Clinical Study teams will be able to enhance the quality of Analysis Results and accelerate Clinical Study Report (CSR) Generation.”

About Clymb Clinical

Clymb Clinical is a clinical data services company leveraging technology-driven solutions to optimize biostatistics, regulatory submissions, and clinical trial reporting. With a mission to innovate, integrate, and improve, Clymb Clinical provides scalable, cost-effective solutions to biotechnology and pharmaceutical companies worldwide.

To learn more about Clymb Clinical and explore TFL Viewer, visit TFL Viewer | Streamline Clinical Trial Data Review or follow Clymb Clinical on LinkedIn for updates. 

View original content to download multimedia:https://www.prnewswire.com/news-releases/clymb-clinical-introduces-tfl-viewer-a-cutting-edge-platform-for-collaborative-clinical-trial-reporting-302462351.html

SOURCE Clymb Clinical

Staff

Recent Posts

GE HealthCare drives innovation in theranostics with latest technological advances

GE HealthCare is helping advance clinical and operational excellence in theranostics and molecular imaging through…

19 hours ago

Saudi Arabia Concludes Landmark BIO 2025 Debut as Kingdom Opens Doors to Global Biotech Collaboration

From genomics to regulatory innovation, the Kingdom’s presence in Boston establishes it as a major…

19 hours ago

Enzon and Viskase Enter into Merger Agreement

Enzon and Viskase stockholders will respectively own approximately 15.9% and 84.1% of the combined companyCRANFORD,…

19 hours ago

Novo Nordisk’s subcutaneous and oral amycretin data published in The Lancet and presented at ADA 2025

Subcutaneous amycretin phase 1b/2a data on the safety, tolerability and weight loss potential in people…

19 hours ago